Uncategorized

How Alnylam Is Taking On Pfizer In A Massive, Growing Market – Investor’s Business Daily

Posted on Author Tim Hodges Comments Off on How Alnylam Is Taking On Pfizer In A Massive, Growing Market – Investor’s Business Daily
  1. How Alnylam Is Taking On Pfizer In A Massive, Growing Market  Investor’s Business Daily
  2. Alnylam’s Amvuttra Approved as First RNAi Silencer for Rare Type of Cardiomyopathy  BioSpace
  3. US FDA expands approval for Alnylam’s drug to treat rare heart disease  Reuters
  4. Alnylam’s Amvuttra wins key approval in ATTR-CM, teeing up showdown with Pfizer  FiercePharma
  5. Alnylam enters the ATTR-CM drug race  STAT